GGO Vergunningendatabase

Zoekcriteria
Zoekresultaat
C/NL/06/01_001 Suntory Flowers Limited Application for renewal of consent for marketing approval under Directive 2001/18/EC (Event FLORIGENE®Moonaqua™(FLO-4Ø689-6)) 09-11-2018 Vergunning verleend
IM-MV 16-003_006 Universitair Medisch Centrum Utrecht Testing the safety and efficacy of KTE-C19 in patients with refractory or relapsed B-cell malignancies 05-02-2019 Vergunning verleend
IM-MV 16-004_004 AMC Testing the safety and efficacy of KTE-C19 in patients with refractory or relapsed B-cell malignancies 05-02-2019 Vergunning verleend
IM-MV 16-005_004 Erasmus MC Testing the safety and efficacy of KTE-C19 in patients with refractory or relapsed B-cell malignancies 07-02-2019 Vergunning verleend
IM-MV 16-007_005 UMCG Testing the safety and efficacy of KTE-C19 in patients with refractory or relapsed B-cell malignancies 14-02-2019 Vergunning verleend
IM-MV 17-002_002 VU medisch centrum Evaluation following the administration of autologous T cells genetically modified with a retroviral vector to express Chimeric Antigen Receptors (CAR) in subject with malignant diseases 05-02-2019 Vergunning verleend
IM-MV 18-016_000 Erasmus MC Testing CTL019 in patients with B cell malignancies 22-02-2019 Vergunning verleend
IM-MV 18-017_000 Universitair Medisch Centrum Utrecht A Study of BAY 2599023 (DTX201), an Adeno-Associated Virus (AAV) hu37-Mediated Gene Transfer of B-Domain Deleted Human Factor VIII, in patients with Severe Hemophilia A 22-02-2019 Vergunning verleend
IM-MV 18-018_000 AMC A Study of BAY 2599023 (DTX201), an Adeno-Associated Virus (AAV) hu37-Mediated Gene Transfer of B-Domain Deleted Human Factor VIII, in patients with Hemophilia A 22-02-2019 Vergunning verleend
IM-MV 18-019_000 Universitair Medisch Centrum Utrecht Testing CTL019 in patients with B cell malignancies 22-02-2019 Vergunning verleend
IM-MV 18-020_000 UMCG A Study of BAY 2599023 (DTX201), an Adeno-Associated Virus (AAV) hu37-Mediated Gene Transfer of B-Domain Deleted Human Factor VIII, in patients with Severe Hemophilia A 22-02-2019 Vergunning verleend